Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment

被引：0
|
作者：
Rafael Morales-Barrera
Guillermo Villacampa
Natalia Vidal
Mariona Figols
Julia Giner
Teresa Bonfill
Cristina Suárez
Nely Díaz
Joaquín Mateo
Macarena González
Montserrat Domenech
Javier Puente
Joan Carles
机构：
[1] Vall d’Hebron Institute of Oncology,Department of Medical Oncology
[2] Vall d’ Hebron University Hospital,Oncology Data Science (OdysSey) Group
[3] Universitat Autònoma de Barcelona,Medical Oncology Department
[4] Vall d’Hebron Institute of Oncology (VHIO),Medical Oncology Department
[5] The Institute of Cancer Research,Medical Oncology
[6] Hospital Clínico San Carlos,undefined
[7] Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC),undefined
[8] CIBERONC,undefined
[9] Fundació Althaia Manresa,undefined
[10] Parc Taulí Hospital Universitari,undefined
[11] Institut d’Investigació i Innovació Parc Taulí I3PT,undefined
来源：
Clinical and Translational Oncology | 2023年 / 25卷
关键词：
Immune checkpoint inhibitors; Immune-related adverse events; Overall response rate; Survival; Urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3556 / 3564
页数：8
相关论文
共 50 条
  • [21] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    ONCOLOGIST, 2023, : 1072 - 1078
  • [22] Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor-induced renal immune-related adverse events
    Zheng, Ke
    Qiu, Wei
    Wang, Hanping
    Si, Xiaoyan
    Zhang, Xiaotong
    Zhang, Li
    Li, Xuemei
    THORACIC CANCER, 2020, 11 (06) : 1746 - 1751
  • [23] Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational Study
    Masaki, Kou
    Miyazaki, Motoyasu
    Kakimoto, Hideki
    Fukiage, Yuma
    Fukue, Haruka
    Nakashima, Akio
    Imakyure, Osamu
    Sparreboom, Alex
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [24] Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis
    Ezdoglian, Aiarpi
    Tsang-A-Sjoe, Michel
    Khodadust, Fatemeh
    Burchell, George
    Jansen, Gerrit
    de Gruijl, Tanja
    Labots, Mariette
    van der Laken, Conny J.
    CANCER AND METASTASIS REVIEWS, 2025, 44 (01)
  • [25] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Zhong, Li
    Wu, Qing
    Chen, Fuchun
    Liu, Junjin
    Xie, Xianhe
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2559 - 2576
  • [26] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
  • [27] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Wang, Jingting
    Ma, Yan
    Lin, Haishan
    Wang, Jing
    Cao, Bangwei
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [28] Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events
    Isik, Busra
    Alexander, Mariam P.
    Manohar, Sandhya
    Vaughan, Lisa
    Kottschade, Lisa
    Markovic, Svetomir
    Lieske, John
    Kukla, Aleksandra
    Leung, Nelson
    Herrmann, Sandra M.
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 1022 - 1031
  • [29] Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Martini, Dylan J.
    Goyal, Subir
    Liu, Yuan
    Evans, Sean T.
    Olsen, T. Anders
    Case, Katherine
    Magod, Benjamin L.
    Brown, Jacqueline T.
    Yantorni, Lauren
    Russler, Greta Anne
    Caulfield, Sarah
    Goldman, Jamie M.
    Nazha, Bassel
    Harris, Wayne B.
    Kissick, Haydn T.
    Master, Viraj A.
    Kucuk, Omer
    Carthon, Bradley C.
    Bilen, Mehmet Asim
    ONCOLOGIST, 2021, 26 (10) : E1742 - E1750
  • [30] Correlation Between Immune-Related Adverse Events and Efficacy of Immune-Checkpoint Inhibitors in Patients with Non-Small Cell Lung Cancer
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    Del Carpio Huerta, L.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Genua Trullos, I.
    Tuneu Valls, L.
    Stantonyonge Sesnic, N.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruellal, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S485 - S486
12345